Back to announcement
20230731_INAF_Laporan Informasi dan Fakta Material_31356353.pdf
Financial statement Text extracted INAFSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 0739/CRS/VII/2023
Nama Perusahaan Indofarma Tbk.
Kode Emiten INAF
Lampiran 3
Laporan Informasi atau Fakta Material Penyampaian Laporan Keuangan
Perihal
Tengah Tahun 2023
Dengan ini kami untuk dan atas nama perusahaan menyampaikan Laporan Informasi atau Fakta Material sebagai
berikut:
Nama Emiten atau Perusahaan Publik Indofarma Tbk.
Bidang Usaha Industri Farmasi dan Kesehatan
Telepon (021) 8832 3971/75; 8590 8349/50
Faksimili (021) 8832 3972/73; 857 4503
Alamat Surat Elektronik (email) corsec@indofarma.id dan headoffice@indofarma.id
Tanggal Kejadian 31 Juli 2023
Jenis Informasi atau Fakta Material Penyampaian Laporan Keuangan Tengah Tahun 2023
Uraian Informasi atau Fakta Material Penyampaian Laporan Keuangan Tengah Tahun 2023.
Dampak kejadian, informasi atau fakta -
material tersebut terhadap kegiatan
operasional, hukum, kondisi keuangan,
atau kelangsungan usaha Emiten atau
Perusahaan Publik
Demikian untuk diketahui.
Hormat Kami,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Telepon : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Nama Pengirim Warjoko Sumedi
Jabatan Corporate Secretary
Page 2
Tanggal dan Waktu 31-07-2023 20:23
Lampiran 1. S Penyampaian TW 2 2023.pdf
2. Surat Pernyataan Direksi LK TW 2 PT INAF 2023.pdf
3. LK INAF Konsolidasi Juni 2023.pdf
Dokumen ini merupakan dokumen resmi Indofarma Tbk. yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Indofarma Tbk. bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 0739/CRS/VII/2023
Issuer Name Indofarma Tbk.
Issuer Code INAF
Attachment 3
Subject Material Information or Facts Report Submission of Mid Year 2023 Financial
Statements
The company hereby announce the Material Information or Facts Report as follows
Name of Issuer or Public Company Indofarma Tbk.
Business Activities Industri Farmasi dan Kesehatan
Telephone (021) 8832 3971/75; 8590 8349/50
Faximile (021) 8832 3972/73; 857 4503
Email Address corsec@indofarma.id dan headoffice@indofarma.id
Date of Event 31 July 2023
Submission of Mid Year 2023 Financial Statements
Type of Material Information or Facts
Description of Material Information or Submission of Mid Year 2023 Financial Statements.
Facts
Impact of event, material information or -
facts towards Issuers or Public
Company’s operational activities, legal,
financial condition, or going concern
Thus to be informed accordingly.
Respectfully,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Phone : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Sender Name Warjoko Sumedi
Function Corporate Secretary
Date and Time 31-07-2023 20:23
Page 4
Attachment 1. S Penyampaian TW 2 2023.pdf
2. Surat Pernyataan Direksi LK TW 2 PT INAF 2023.pdf
3. LK INAF Konsolidasi Juni 2023.pdf
This is an official document of Indofarma Tbk. that does not require a signature as it was generated electronically
by the electronic reporting system. Indofarma Tbk. is fully responsible for the information contained within this
document.
Names mentioned 0 people and organisations named in the text · linked when the evidence is strong
The name pass has not read this document yet.
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.